Skip to main content
. 2012 May 8;287(26):22408–22417. doi: 10.1074/jbc.M112.357301

TABLE 1.

Apoptosis results of cells treated with GMX1778 repeated in triplicate were used for calculating average ± S.D. as in Fig. 5

GMX1778 concentrations used are in parentheses, and 20 μm NA was added concurrently with GMX1778.

Cell line % apoptotic cells (annexin-V-positive)
Control GMX1778 GMX1778+ NA
U251 (5 nm) 11.9 ± 3.5 86.2 ± 5.3a 88.7 ± 2.6
HCT116 (5 nm) 12.8 ± 3.5 46.8 ± 6.3a 11.6 ± 2.4b
HCT116 p53−/− (5 nm) 11.7 ± 3.0 37.0 ± 4.5c 10.5 ± 2.9b
MDA-MB-231 BR (15 nm) 8.0 ± 4.8 93.8 ± 4.4a 90.8 ± 1.2
HMEC (50 nm) 10.0 ± 0.7 14.4 ± 2.5 10.8 ± 1.8
MCF10A (50 nm) 20.3 ± 7.8 17.1 ± 7.5 17.6 ± 4.2

a p ≤ 0.001 compared with control.

b p ≤ 0.001 compared with GMX1778 alone.

c Increased cell death (p ≤ 0.05).